Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $138.5 million.

  • Conmed's Other Accumulated Expenses rose 2617.78% to $138.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $138.5 million, marking a year-over-year increase of 2617.78%. This contributed to the annual value of $138.5 million for FY2025, which is 2617.78% up from last year.
  • Conmed's Other Accumulated Expenses amounted to $138.5 million in Q4 2025, which was up 2617.78% from $130.7 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Other Accumulated Expenses ranged from a high of $163.5 million in Q3 2023 and a low of $62.5 million during Q1 2022
  • In the last 5 years, Conmed's Other Accumulated Expenses had a median value of $112.7 million in 2024 and averaged $108.9 million.
  • As far as peak fluctuations go, Conmed's Other Accumulated Expenses soared by 10431.27% in 2023, and later plummeted by 2928.82% in 2024.
  • Quarter analysis of 5 years shows Conmed's Other Accumulated Expenses stood at $65.7 million in 2021, then surged by 50.17% to $98.7 million in 2022, then skyrocketed by 53.76% to $151.7 million in 2023, then fell by 27.63% to $109.8 million in 2024, then grew by 26.18% to $138.5 million in 2025.
  • Its Other Accumulated Expenses stands at $138.5 million for Q4 2025, versus $130.7 million for Q3 2025 and $125.1 million for Q2 2025.